Arch Therapeutics Novel Self-Assembling Agent for Use in Endoscopic Procedures to be Presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2020 Annual Meeti...
Arch Therapeutics, Inc. (ARTH)
NASDAQ:AMEX Investor Relations:
ir.archtherapeutics.com
Company Research
Source: GlobeNewswire
FRAMINGHAM, Mass., March 04, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today announced that new research from the AC5® self-assembling peptide technology platform will be presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2020 Annual Meeting. The conference will be held on April 1-4, 2020 at the Huntington Convention Center in Cleveland, OH. The Arch abstract, “Novel endoscopic self-assembling agent for use in submucosal lifting in endoscopic resection and management of gastrointestinal bleeding,” by Eleanor C. Fung, MD, Jay Redan, MD, Chirag Shah, PhD and Terrence Norchi, MD, has been accepted by SAGES and selected for a podium presentation in the Emerging Technology Session on Thursday, April 2 at 10 A.M. EDT in room 25 A-C. Dr. Fung will deliver the presentation. Dr. Redan and Dr. Norchi will also attend the meeting an
Show less
Read more
Impact Snapshot
Event Time:
ARTH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARTH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARTH alerts
High impacting Arch Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
ARTH
Sec Filings
- 11/13/24 - Form SC
- 11/7/24 - Form 8-K
- 11/4/24 - Form 8-K
- ARTH's page on the SEC website